Retrotransposition-Competent Human LINE-1 Induces Apoptosis in Cancer Cells With Intact p53
AUTOR(ES)
Haoudi, Abdelali
FONTE
Hindawi Publishing Corporation
RESUMO
Retrotransposition of human LINE-1 (L1) element, a major representative non-LTR retrotransposon in the human genome, is known to be a source of insertional mutagenesis. However, nothing is known about effects of L1 retrotransposition on cell growth and differentiation. To investigate the potential for such biological effects and the impact that human L1 retrotransposition has upon cancer cell growth, we examined a panel of human L1 transformed cell lines following a complete retrotransposition process. The results demonstrated that transposition of L1 leads to the activation of the p53-mediated apoptotic pathway in human cancer cells that possess a wild-type p53. In addition, we found that inactivation of p53 in cells, where L1 was undergoing retrotransposition, inhibited the induction of apoptosis. This suggests an association between active retrotransposition and a competent p53 response in which induction of apoptosis is a major outcome. These data are consistent with a model in which human retrotransposition is sensed by the cell as a “genetic damaging event” and that massive retrotransposition triggers signaling pathways resulting in apoptosis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=555774Documentos Relacionados
- Prima-1 induces apoptosis in bladder cancer cell lines by activating p53
- E2F1 Induces Phosphorylation of p53 That Is Coincident with p53 Accumulation and Apoptosis
- p53 inhibition of AP1-dependent TFF2 expression induces apoptosis and inhibits cell migration in gastric cancer cells
- Frequent Human Genomic DNA Transduction Driven by LINE-1 Retrotransposition
- Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.